Skip to main content
. Author manuscript; available in PMC: 2022 May 28.
Published in final edited form as: Cancer. 2020 May 15;126(14):3322–3329. doi: 10.1002/cncr.32941

Figure 2.

Figure 2

Figure 2A: Cumulative incidence of any subsequent malignant neoplasms in aBMT survivors by IMiD exposure

Figure 2B: Cumulative incidence of Solid Tumors in aBMT survivors by IMiD exposure

Figure 2C: Cumulative incidence of Melanoma in aBMT survivors by IMiD exposure

Figure 2D: Cumulative incidence of SCC in aBMT survivors by IMiD exposure

Abbreviations: aBMT: Autologous blood or marrow transplantation, SCC: squamous cell carcinoma, IMiD: Immunomodulatory drugs